Literature DB >> 4219951

Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans.

J Fleck, M Mock, F Tytgat, C Nauciel, R Minck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4219951     DOI: 10.1038/250517b0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

2.  Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvant.

Authors:  F Audibert; L Chedid
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

3.  Hydrosoluble immunostimulants of bacterial and synthetic origins.

Authors:  P Jollès
Journal:  Experientia       Date:  1976-06-15

4.  Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.

Authors:  Hiroyuki Tada; Setsuya Aiba; Ken-Ichiro Shibata; Toshiaki Ohteki; Haruhiko Takada
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 5.  Toll or toll-free adjuvant path toward the optimal vaccine development.

Authors:  Ken J Ishii; Shizuo Akira
Journal:  J Clin Immunol       Date:  2007-03-17       Impact factor: 8.317

6.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.

Authors:  A Tanaka; R Saito; K Sugiyama; I Morisaki; S Kotani
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Adjuvant activities of chemically modified water-soluble substances from Mycobacterium tuberculosis.

Authors:  D Migliore-Samour; F Floc'h; R Maral; G H Werner; P Jollès
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.